Performance of Different Diagnostic Criteria for Familial Mediterranean Fever in Children with Periodic Fevers: Results from a Multicenter International Registry

Objective. Our aims were to validate the pediatric diagnostic criteria in a large international registry and to compare them with the performance of previous criteria for the diagnosis of familial Mediterranean fever (FMF). Methods. Pediatric patients with FMF from the Eurofever registry were used for the validation of the existing criteria. The other periodic fevers served as controls: mevalonate kinase deficiency (MKD), tumor necrosis factor receptor–associated periodic syndrome (TRAPS), cryopyrin-associated periodic syndrome (CAPS), aphthous stomatitis, pharyngitis, adenitis syndrome (PFAPA), and undefined periodic fever from the same registry. The performances of Tel Hashomer, Livneh, and the Yalcinkaya-Ozen criteria were assessed. Results. The FMF group included 339 patients. The control group consisted of 377 patients (53 TRAPS, 45 MKD, 32 CAPS, 160 PFAPA, 87 undefined periodic fevers). Patients with FMF were correctly diagnosed using the Yalcinkaya-Ozen criteria with a sensitivity rate of 87.4% and a specificity rate of 40.7%. On the other hand, Tel Hashomer and Livneh criteria displayed a sensitivity of 45.0 and 77.3%, respectively. Both of the latter criteria displayed a better specificity than the Yalcinkaya-Ozen criteria: 97.2 and 41.1% for the Tel Hashomer and Livneh criteria, respectively. The overall accuracy for the Yalcinkaya-Ozen criteria was 65 and 69.6% (using 2 and 3 criteria), respectively. Ethnicity and residence had no effect on the performance of the Yalcinkaya-Ozen criteria. Conclusion. The Yalcinkaya-Ozen criteria yielded a better sensitivity than the other criteria in this international cohort of patients and thus can be used as a tool for FMF diagnosis in pediatric patients from either the European or eastern Mediterranean region. However, the specificity was lower than the previously suggested adult criteria.

[1]  M. Sormani,et al.  Evidence-based provisional clinical classification criteria for autoinflammatory periodic fevers , 2015, Annals of the rheumatic diseases.

[2]  P. Woo,et al.  Results from a multicentre international registry of familial Mediterranean fever: impact of environment on the expression of a monogenic disease in children , 2013, Annals of the rheumatic diseases.

[3]  A. Polat,et al.  Recent advances in the management of children with familial Mediterranean fever , 2013 .

[4]  S. Özen,et al.  Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review , 2012, Annals of the rheumatic diseases.

[5]  C. Wouters,et al.  An International registry on Autoinflammatory diseases: the Eurofever experience , 2012, Annals of the rheumatic diseases.

[6]  S. Ozen,et al.  A Glance at History and Future Perspectives of Childhood Autoinflammatory Disorders , 2012 .

[7]  F. Yalçınkaya,et al.  Why a New Diagnostic Criteria for Pediatric Familial Mediterranean Fever Patients , 2012 .

[8]  M. Eki̇m,et al.  Application of the new pediatric criteria and Tel Hashomer criteria in heterozygous patients with clinical features of FMF , 2011, European Journal of Pediatrics.

[9]  I. Koné-Paut,et al.  Validation of the new paediatric criteria for the diagnosis of familial Mediterranean fever: data from a mixed population of 100 children from the French reference centre for auto-inflammatory disorders. , 2010, Rheumatology.

[10]  Isabelle Touitou,et al.  Familial mediterranean Fever in the world. , 2009, Arthritis and rheumatism.

[11]  A. Elhan,et al.  A new set of criteria for the diagnosis of familial Mediterranean fever in childhood. , 2009, Rheumatology.

[12]  I. Dalal,et al.  Colchicine prophylaxis for frequent periodic fever, aphthous stomatitis, pharyngitis and adenitis episodes , 2008, Acta paediatrica.

[13]  A. Bakkaloğlu,et al.  Mutation frequency of Familial Mediterranean Fever and evidence for a high carrier rate in the Turkish population , 2001, European Journal of Human Genetics.

[14]  M. Tekin,et al.  Genotype-phenotype correlation in a large group of Turkish patients with familial mediterranean fever: evidence for mutation-independent amyloidosis. , 2000, Rheumatology.

[15]  M. Pras,et al.  MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean fever. , 1999, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[16]  A. Bakkaloğlu,et al.  Prevalence of juvenile chronic arthritis and familial Mediterranean fever in Turkey: a field study. , 1998, The Journal of rheumatology.

[17]  D. Zemer,et al.  Criteria for the diagnosis of familial Mediterranean fever. , 1997, Arthritis and rheumatism.

[18]  F. Collins,et al.  Ancient Missense Mutations in a New Member of the RoRet Gene Family Are Likely to Cause Familial Mediterranean Fever , 1997, Cell.

[19]  T Sherwood,et al.  Evaluation of diagnostic tests. , 1989, Clinical radiology.

[20]  S. Goldfinger Colchicine for familial Mediterranean fever. , 1972, The New England journal of medicine.

[21]  E. Sohar,et al.  FAMILIAL MEDITERRANEAN FEVER , 1959, Definitions.